10 Steps That Risk Failure in the Temperature Controlled Clinical Supply Chain

Whitepaper

Maintaining product integrity is essential. If you are developing a drug that requires temperature management, eliminating the risk of an excursion throughout the supply chain is critical. Once your Investigational Medicinal Product (IMP) leaves your development facility, there are numerous points where it can be at risk.

Download this infographic to understand the questions you should be asking to be better positioned to ensure zero excursions and maximum product integrity.